Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
geminin | 2 | 0 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
thioredoxin reductase | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
GLS protein | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 2 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
Luciferase | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
RAR-related orphan receptor gamma | 2 | 0 | 0 | 2 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
USP1 protein, partial | 2 | 0 | 0 | 2 |
PPM1D protein | 2 | 0 | 0 | 2 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
TDP1 protein | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 1 | 0 | 0 | 1 |
AR protein | 3 | 0 | 0 | 3 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
progesterone receptor | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 1 | 0 | 0 | 1 |
retinoic acid nuclear receptor alpha variant 1 | 2 | 0 | 0 | 2 |
retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 2 | 0 | 0 | 2 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
estrogen nuclear receptor alpha | 2 | 0 | 0 | 2 |
G | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
caspase-3 | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
Histone H2A.x | 2 | 0 | 0 | 2 |
Caspase-7 | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
Cytochrome P450 26A1 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Interferon beta | 2 | 0 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Retinoic acid receptor alpha | 0 | 1 | 3 | 4 |
Retinoic acid receptor beta | 0 | 1 | 3 | 4 |
Retinoic acid receptor gamma | 0 | 1 | 3 | 4 |
Glutamate receptor 2 | 2 | 0 | 0 | 2 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 5 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 1 | 1 |
Retinoic acid receptor RXR-beta | 0 | 1 | 1 | 2 |
Retinoic acid receptor RXR-beta | 0 | 0 | 2 | 2 |
Retinoic acid receptor RXR-gamma | 0 | 0 | 2 | 2 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Retinoic acid receptor RXR-gamma | 0 | 1 | 1 | 2 |
Type-2 angiotensin II receptor | 0 | 0 | 1 | 1 |
Oxysterols receptor LXR-beta | 0 | 0 | 1 | 1 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 1 | 1 |
Oxysterols receptor LXR-alpha | 0 | 0 | 1 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
Ataxin-2 | 1 | 0 | 0 | 1 |
Cytochrome P450 26B1 | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 3 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 3 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 3 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 3 |
Serine racemase | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 3 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Insulin-like growth factor 1 receptor | 0 | 1 | 0 | 1 |
Platelet-derived growth factor receptor beta | 0 | 1 | 0 | 1 |
Fibroblast growth factor receptor 1 | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Fibroblast growth factor receptor 1 | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |